Personalis News

Personalis (PSNL) Receives a Buy From Lake Street

TipRanksMay 28 08:55 ET

Analysts Offer Insights on Healthcare Companies: Personalis (PSNL) and G1 Therapeutics (GTHX)

TipRanksMay 22 09:10 ET

Personalis (PSNL) Receives a Buy From Lake Street

TipRanksMay 9 08:57 ET

Analysts Offer Insights on Healthcare Companies: Legend Biotech (LEGN), Revolution Medicines (RVMD) and Personalis (PSNL)

TipRanksMay 9 06:40 ET

Personalis Analyst Ratings

BenzingaMay 9 05:57 ET

Buy Rating Affirmed for Personalis Amid Strong Financial Performance and Strategic Growth Prospects

TipRanksMay 9 05:55 ET

Personalis Analyst Ratings

BenzingaApr 30 11:42 ET

Buy Rating Affirmed for Personalis, Inc. on Strong Growth Prospects and Innovative Cancer Assays

TipRanksApr 11 08:25 ET

Personalis Analyst Ratings

BenzingaApr 11 08:14 ET

Buy Rating Affirmed: Personalis's Strategic Advances and Financial Health Signal Promising Growth in 2024

TipRanksMar 4 05:49 ET

Buy Rating Affirmed for Personalis Amidst Strategic Partnerships and Revenue Growth Prospects

TipRanksMar 1 06:58 ET

Analysts Offer Insights on Healthcare Companies: Sensei Biotherapeutics (SNSE), Abbott Labs (ABT) and Personalis (PSNL)

TipRanksFeb 29 06:50 ET

Analysts Are Bullish on Top Healthcare Stocks: RxSight (RXST), Personalis (PSNL)

TipRanksFeb 29 05:20 ET

Needham Reiterates Buy on Personalis, Maintains $2.3 Price Target

BenzingaJan 5 13:09 ET

Personalis Analyst Ratings

BenzingaJan 5 13:08 ET

Buy Rating for Personalis Amid Strong Growth and Promising VA MVP Developments

TipRanksJan 5 12:35 ET

BTIG Keeps Their Buy Rating on Personalis (PSNL)

TipRanksJan 2 09:32 ET

Buy Rating for Personalis (PSNL) Amid Tempus Partnership and Market Expansion Potential

TipRanksDec 1, 2023 08:16 ET

Needham Maintains Buy on Personalis, Lowers Price Target to $2.3

BenzingaNov 8, 2023 11:26 ET

Personalis Analyst Ratings

BenzingaNov 8, 2023 11:25 ET